GLSI

Greenwich Lifesciences Inc

• NASDAQ·08/21 02:38

  After-hours Gainers: HOWL Jumps 90%, MODD To Begin Pivot Pump Rollout, BIVI Awaits Long COVID Data

• Benzinga·08/10 10:07

  Greenwich LifeSciences Extends 100% Insider Share Lock‑Up To January 31, 2027

• TipRanks·07/31 02:05

  Top Executive Doubles Down on Greenwich LifeSciences With Fresh Insider Buy

• TipRanks·07/30 02:01

  Top Executive Makes Bold Insider Move on Biotech Stock

• TipRanks·07/28 02:02

  Top Executive Makes Bold Insider Move at Greenwich LifeSciences

• TipRanks·07/22 10:20

  Greenwich receives regulatory approval to expand Flamingo-01 in the U.K.

• Dow Jones·07/21 17:14

  Greenwich LifeSciences Price Target Raised to $69.00/Share From $50.00 by HC Wainwright & Co.

• Dow Jones·07/21 17:14

  Greenwich LifeSciences Is Maintained at Buy by HC Wainwright & Co.

• Benzinga·07/21 17:03

  HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $69

• TipRanks·07/21 16:20

  Greenwich LifeSciences price target raised to $69 from $50 at H.C. Wainwright

• Seeking Alpha·07/21 13:49

  Greenwich LifeSciences: Building Pivotal Trial Momentum, But Still Not Moving The Needle For Me

• NASDAQ·07/20 13:56

  Greenwich Advances FLAMINGO-01 Phase III Trial With Strategic Enrollment Changes

• Benzinga·07/20 10:10

  Greenwich LifeSciences Expects Q2 Cash Burn To Be ~$2M, Down From $4.7M In Q1, With Cash Balance Of ~$8.9M As Of June And Expected Burn Rate Of $2-4M Per Quarter Going Forward

• TipRanks·07/20 10:05

  Greenwich LifeSciences provides clinical and financial updates on Flamingo-01

• NASDAQ·07/17 20:36

  Greenwich LifeSciences Becomes Oversold (GLSI)